Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias

British Journal of Haematology

Volumn 135, Issue 4, 2006, Pages 500-508

  Uckun, Fatih M ^a   Morar, Sanda ^a   Qazi, Sanjive ^a  

^a Parker Hughes Cancer Center   (United States)

Author keywords

Apoptosis; Drug sensitivity; Flow cytometry; Leukaemia; Tubulin

Indexed keywords

ASPARAGINASE; CHLORAMBUCIL; CLADRIBINE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; HYDROXYUREA; IFOSFAMIDE; IMATINIB; METHOTREXATE; MITOXANTRONE; NAVELBINE; PREDNISONE; RITUXIMAB; THIOTEPA; TOPOTECAN; VINCA ALKALOID; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BLAST CELL CRISIS; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DRUG EFFICACY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; LEUKEMIA CELL; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CHILD; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; SALVAGE THERAPY; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 33750071398     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06338.x     Document Type: Article

References (61)

1. Abbott, B.L. (2006) Chronic lymphocytic leukemia: recent advances in diagnosis and treatment. Oncologist, 11, 21-30.
2. Annino, L., Vegna, M.L., Camera, A., Specchia, G., Visani, G., Fioritoni, G., Ferrara, F., Peta, A., Ciolli, S., Deplano, W., Fabbiano, F., Sica, S., Di Raimondo, F., Cascavilla, N., Tabilio, A., Leoni, P., Invernizzi, R., Baccarani, M., Rotoli, B., Amadori, S. & Mandelli, F. (2002) Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood, 99, 863-871.
3. Bloomfield, C.D., Mrozek, K. & Caligiuri, M.A. (2006) Cancer and leukemia group B leukemia correlative science committee: major accomplishments and future directions. Clincal Cancer Research, 12, 3564s-3571s.
4. Boissel, N., Auclerc, M.F., Lheritier, V., Perel, Y., Thomas, X., Leblanc, T., Rousselot, P., Cayuela, J.M., Gabert, J., Fegueux, N., Piguet, C., Huguet-Rigal, F., Berthou, C., Boiron, J.M., Pautas, C., Michel, G., Fiere, D., Leverger, G., Dombret, H. & Baruchel, A. (2003) Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. Journal of Clinical Oncology, 21, 774-780.
5. de Bont, J.M., Holt, B., Dekker, A.W., van der Does-van den Berg, A., Sonneveld, P. & Pieters, R. (2004) Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric versus adult protocols in the Netherlands. Leukemia, 18, 2032-2035.
6. Byrd, J.C., Lin, T.S. & Grever, M.R. (2006) Treatment of relapsed chronic lymphocytic leukemia: old and new therapies. Seminars in Oncology, 33, 210-219.
7. Chessells, J.M., Veys, P., Kempski, H., Henley, P., Leiper, A., Webb, D. & Hann, I.M. (2003) Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. British Journal of Haematology, 123, 396-405.
8. Conter, V., Arico, M., Valsecchi, M.G., Basso, G., Biondi, A., Madon, E., Mandelli, F., Paolucci, G., Pession, A., Rizzari, C., Rondelli, R., Zanesco, L. & Masera, G. (2000) Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995. Leukemia, 14, 2196-2204.
9. Cortes, J. (2006) Overcoming drug resistance in chronic myeloid leukemia. Current Opinion in Hematology, 13, 79-86.
10. Debatin, K.M. & Krammer, P.H. (2004) Death receptors in chemotherapy and cancer. Oncogene, 23, 2950-2966.
11. Di Renzo, N., Brugiatelli, M., Montanini, A., Vigliotti, M.L., Cervetti, G., Liberati, A.M., Luminari, S., Spedini, P., Giglio, G. & Federico, M. (2006) Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi. Leukemia and Lymphoma, 47, 473-479.
12. Dutcher, J.P. & Wiernik, P.H. (2000) Accelerated and blastic phase of chronic myeloid leukemia. Current Treatment Options in Oncology, 1, 51-62.
13. Einsiedel, H.G., von Stackelberg, A., Hartmann, R., Fengler, R., Schrappe, M., Janka-Schaub, G., Mann, G., Hahlen, K., Gobel, U., Klingebiel, T., Ludwig, W.D. & Henze, G. (2005) Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. Journal of Clinical Oncology, 23, 7942-7950.
14. Fulda, S. & Debatin, K.M. (2004) Targeting apoptosis pathways in cancer therapy. Current Cancer Drug Targets, 4, 569-576.
15. Gaynon, P.S. (2005) Childhood acute lymphoblastic leukaemia and relapse. British Journal of Haematology, 131, 579-587.
16. Gentile, M., Mauro, F.R., Guarini, A. & Foa, R. (2005) New developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemia. Current Opinion in Oncology, 17, 597-604.
17. Gregory, R.K. & Smith, I.E. (2000) Vinorelbine - a clinical review. British Journal of Cancer, 82, 1907-1913.
18. Hoelzer, D. & Gokbuget, N. (2000) New approaches to acute lymphoblastic leukemia in adults: where do we go? Seminars in Oncology, 27, 540-559.
19. Johansen, M., Kuttesch, J., Bleyer, W.A., Krailo, M., Ames, M. & Madden, T. (2006) Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group. Clinical Cancer Research, 12, 516-522.
20. Johnson, I.S. & Wright, H.F. (1960) Therapeutic activity of basic bisepoxides in murine leukemia and other transplantable mouse neoplasms. Acta - Unio Internationalis Contra Cancrum, 16, 676-681.
21. Johnstone, R.W., Ruefli, A.A. & Lowe, S.W. (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell, 108, 153-164.
22. Kamps, W.A., Bokkerink, J.P., Hakvoort-Cammel, F.G., Veerman, A.J., Weening, R.S., van Wering, E.R., van Weerden, J.F., Hermans, J., Slater, R., van den Berg, E., Kroes, W.G. & van der Does-van den Berg, A. (2002) BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996). Leukemia, 16, 1099-1111.
23. Kantarjian, H., Thomas, D., O'Brien, S., Cortes, J., Giles, F., Jeha, S., Bueso-Ramos, C.E., Pierce, S., Shan, J., Koller, C., Beran, M., Keating, M. & Freireich, E.J. (2004) Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer, 101, 2788-2801.
24. Kaufmann, S.H. & Vaux, D.L. (2003) Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene, 22, 7414-7430.
25. Kim, R. (2005) Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer, 103, 1551-1560.
26. Kolb, E.A. & Steinherz, P.G. (2003) A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia. Leukemia, 17, 1967-1972.
27. Krishnan, B., Matutes, E. & Dearden, C. (2006) Prolymphocytic leukemias. Seminars in Oncology, 33, 257-263.
28. Larson, R.A. (2004) The U.S. trials in adult acute lymphoblastic leukemia. Annals of Hematology, 83 (Suppl. 1), S127-128.
29. Lee, S.J. (2000) Chronic myelogenous leukaemia. British Journal of Haematology, 111, 993-1009.
30. Linker, C., Damon, L., Ries, C. & Navarro, W. (2002) Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Journal of Clinical Oncology, 20, 2464-2471.
31. Mathe, G. & Reizenstein, P. (1985) Phase I pharmacologic study of a new Vinca alkaloid: navelbine. Cancer Letters, 27, 285-293.
32. Monfardini, S., Aversa, S.M., Zoli, V., Salvagno, L., Bianco, A., Bordonaro, R., Benevolo, G., Crugnola, M., Crivellari, G., Vivaldi, P., Basso, U. & Torri, V. (2005) Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas. Annals of Oncology, 16, 1352-1358.
33. Muller-Beissenhirtz, H., Kasper, C., Nuckel, H. & Duhrsen, U. (2005) Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study. Annals of Hematology, 84, 796-801.
34. Nachman, J. (2005) Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia. British Journal of Haematology, 130, 166-173.
35. Narla, R.K., Dong, Y., Klis, D. & Uckun, F.M. (2001a) Bis (4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium (I.V.) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity. Clinical Cancer Research, 7, 1094-1101.
36. Narla, R.K., Dong, Y. & Uckun, F.M. (2001b) Apoptosis inducing novel anti-leukemic agent, bis (4,7-dimethyl-1,10 phenanthroline) sulfatooxovanadium (IV) [VO (SO4) (Me2-Phen)2] depolarizes mitochondrial membranes. Leukemia and Lymphoma, 41, 625-634.
37. Papageorgiou, E.S., Tsirigotis, P., Dimopoulos, M., Pavlidis, N., Fountzilas, G., Papageorgiou, S. & Economopoulos, T. (2005) Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group. European Journal of Haematology, 75, 124-129.
38. Pui, C.H. & Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine, 354, 166-178.
39. Reaman, G.H., Sposto, R., Sensel, M.G., Lange, B.J., Feusner, J.H., Heerema, N.A., Leonard, M., Holmes, E.J., Sather, H.N., Pendergrass, T.W., Johnstone, H.S., O'Brien, R.T., Steinherz, P.G., Zeltzer, P.M., Gaynon, P.S., Trigg, M.E. & Uckun, F.M. (1999) Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. Journal of Clinical Oncology, 17, 445-455.
40. Sarris, A.H., Psyrri, A., Hagemeister, F., Romaguera, J., McLaughlin, P., Rodriguez, M.A., Bachier, C., Younes, A., Mesina, O., Oholendt, M., Medeiros, L.J., Samuels, B., Adams, L.M. & Cabanillas, F. (2000) Infusional vinorelbine in relapsed or refractory lymphomas. Leukemia and Lymphoma, 39, 291-299.
41. Takeuchi, J., Kyo, T., Naito, K., Sao, H., Takahashi, M., Miyawaki, S., Kuriyama, K., Ohtake, S., Yagasaki, F., Murakami, H., Asou, N., Ino, T., Okamoto, T., Usui, N., Nishimura, M., Shinagawa, K., Fukushima, T., Taguchi, H., Morii, T., Mizuta, S., Akiyama, H., Nakamura, Y., Ohshima, T. & Ohno, R. (2002) Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Leukemia, 16, 1259-1266.
42. Thomas, X., Boiron, J.M., Huguet, F., Dombret, H., Bradstock, K., Vey, N., Kovacsovics, T., Delannoy, A., Fegueux, N., Fenaux, P., Stamatoullas, A., Vernant, J.P., Tournilhac, O., Buzyn, A., Reman, O., Charrin, C., Boucheix, C., Gabert, J., Lheritier, V. & Fiere, D. (2004) Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. Journal of Clinical Oncology, 22, 4075-4086.
43. Toh, H.C., Sun, L., Koh, C.H. & Aw, S.E. (1998) Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: a comparison with vincristine. Leukemia and Lymphoma, 31, 195-208.
44. Tolomeo, M. & Simoni, D. (2002) Drug resistance and apoptosis in cancer treatment: development of new apoptosis-inducing agents active in drug resistant malignancies. Current Medicinal Chemistry Anti-cancer Agents, 2, 387-401.
45. Trigg, M.E., Gaynon, P.S. & Uckun, F.M. (1997) Acute Lymphoblastic Leukemia in Children, Cancer Medicine. In: Acute Lymphoblastic Leukaemia in Children, 4th edn (ed. by J. Holland, R. Bast, D. Morton, E. Frei, D. Kufe & R. Weichselbaum), Volume 2, Chapter 164, pp. 2945-2960. Williams & Wilkins, Baltimore, MD.
46. Tsimberidou, A.M. & Keating, M.J. (2006) Richter's transformation in chronic lymphocytic leukemia. Seminars in Oncology, 33, 250-256.
47. Uckun, F.M. (2002) Treating chronic leukemias. Minnesota Physician, 16, 14.
48. Uckun, F.M., Tuel-Ahlgren, L., Song, C.W., Waddick, K., Myers, D.E., Kirihara, J., Ledbetter, J.A. & Schieven, G.L. (1992) Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death. Proceedings of the National Academy of Sciences of the United States of America, 89, 9005-9009.
49. Uckun, F.M., Waddick, K.G., Mahajan, S., Jun, X., Takata, M., Bolen, J. & Kurosaki, T. (1996) BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science, 273, 1096-1100.
50. Uckun, F.M., Gaynon, P.S., Sensel, M.G., Nachman, J., Trigg, M.E., Steinherz, P.G., Hutchinson, R., Bostrom, B.C., Sather, H.N. & Reaman, G.H. (1997a) Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study. Journal of Clinical Oncology, 15, 2214-2221.
51. Uckun, F.M., Sather, H.N., Gaynon, P.S., Arthur, D.C., Trigg, M.E., Tubergen, D.G., Nachman, J., Steinherz, P.G., Sensel, M.G. & Reaman, G.H. (1997b) Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood, 90, 28-35.
52. Uckun, F.M., Yang, Z., Sather, H., Steinherz, P., Nachman, J., Bostrom, B., Crotty, L., Sarquis, M., Ek, O., Zeren, T., Tubergen, D., Reaman, G. & Gaynon, P. (1997c) Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study. Blood, 89, 3769-3777.
53. Uckun, F.M., Nachman, J.B., Sather, H.N., Sensel, M.G., Kraft, P., Steinherz, P.G., Lange, B., Hutchinson, R., Reaman, G.H., Gaynon, P.S. & Heerema, N.A. (1998a) Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group. Cancer, 83, 2030-2039.
54. Uckun, F.M., Sensel, M.G., Sun, L., Steinherz, P.G., Trigg, M.E., Heerema, N.A., Sather, H.N., Reaman, G.H. & Gaynon, P.S. (1998b) Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood, 91, 735-746.
55. Uckun, F.M., Nachman, J.B., Sather, H.N., Sensel, M.G., Kraft, P., Steinherz, P.G., Lange, B., Hutchinson, R., Reaman, G.H., Gaynon, P.S. & Heerema, N.A. (1999) Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy. Leukemia and Lymphoma, 33, 101-106.
56. Uckun, F.M., Mao, C., Jan, S.T., Huang, H., Vassilev, A.O., Sudbeck, E.A., Navara, C.S. & Narla, R.K. (2000a) SPIKET and COBRA compounds as novel tubulin modulators with potent anticancer activity. Current Opinion in Investigational Drugs, 1, 252-256.
57. Uckun, F.M., Mao, C., Vassilev, A.O., Navara, C.S., Narla, R.K. & Jan, S.T. (2000b) A rationally designed anticancer drug targeting a unique binding cavity of tubulin. Bioorganic & Medicinal Chemistry Letters, 10, 1015-1018.
58. Uckun, F.M., Sudbeck, E.A., Mao, C., Ghosh, S., Liu, X.P., Vassilev, A.O., Navara, C.S. & Narla, R.K. (2001) Structure-based design of novel anticancer agents. Current Cancer Drug Targets, 1, 59-71.
59. Vilmer, E., Suciu, S., Ferster, A., Bertrand, Y., Cave, H., Thyss, A., Benoit, Y., Dastugue, N., Fournier, M., Souillet, G., Manel, A.M., Robert, A., Nelken, B., Millot, F., Lutz, P., Rialland, X., Mechinaud, F., Boutard, P., Behar, C., Chantraine, J.M., Plouvier, E., Laureys, G., Brock, P., Uyttebroeck, A., Margueritte, G., Plantaz, D., Norton, L., Francotte, N., Gyselinck, J., Waterkeyn, C., Solbu, G., Philippe, N. & Otten, J. (2000) Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia, 14, 2257-2266.
60. Wierda, W.G. & O'Brien, S.M. (2006) Initial therapy for patients with chronic lymphocytic leukemia. Seminars in Oncology, 33, 202-209.
61. Zinzani, P.L., Tani, M., Stefoni, V., Albertini, P., Bendandi, M., Gherlinzoni, F., Alinari, L., Vigna, E. & Tura, S. (2001) Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma. Haematologica, 86, 287-290.